Jim Simons Merrimack Pharmaceuticals Inc Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 13, 2024	BUY	$13.06 - $15.0 $1.48 Million - $1.7 Million	113,284 Added 231.66%	162,184 $2.4 Million
Q4 2023 Feb 13, 2024	BUY	$12.02 - $13.41 $587,778 - $655,749	48,900 New	48,900 $656,000
Q1 2022 May 13, 2022	SELL	$3.75 - $6.82 $72,978 - $132,724	-19,461 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$3.75 - $5.1 $161,471 - $219,600	-43,059 Reduced 68.87%	19,461 $76,000
Q3 2021 Nov 12, 2021	SELL	$4.3 - $6.39 $169,635 - $252,085	-39,450 Reduced 38.69%	62,520 $302,000
Q2 2021 Aug 13, 2021	SELL	$6.04 - $7.77 $520,593 - $669,704	-86,191 Reduced 45.81%	101,970 $652,000
Q1 2021 May 13, 2021	BUY	$6.15 - $8.7 $69,495 - $98,309	11,300 Added 6.39%	188,161 $1.18 Million
Q4 2020 Feb 10, 2021	BUY	$3.69 - $8.31 $652,617 - $1.47 Million	176,861 New	176,861 $1.22 Million
Q1 2020 May 14, 2020	SELL	$1.63 - $3.58 $55,356 - $121,580	-33,961 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$3.15 - $4.67 $106,977 - $158,597	33,961 New	33,961 $107,000

Others Institutions Holding MACK

# of Institutions

2

Shares Held

349

Call Options Held

0

Put Options Held

0

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.